2019-842 Health - Walgreens drug dispense

Browse Search

W�"r40 . benefits , as applicable . The Contracted Rate is Walgreen ' s proprietary and confidential information ; therefore , Covered Entity acknowledges and agrees that it will not request , and Walgreens will not provide , the Contracted Rate or any information which may disclose or enable the Covered Entity to determine the Contracted Rate . 2 . 6 . " Covered Entity Location ( s ) " means those individual Covered Entity locations related to Covered Entity, including all associated eligible child sites , that are listed on the HRSA web - site pursuant to an executed enrollment or registration form which authorizes Covered Entities to contract with a licensed pharmacy to manage and dispense 340B Drugs . Covered Entity Locations shall only be eligible under this Agreement for so long as such locations are registered and identified as active in the HRSA 340B database and for which Covered Entity is the designated billing entity . 2 . 7 . " DHHS " means the United States Department of Health and Human Services . 2 . 8 . " Eligible Patient ( s ) " means those Covered Entity outpatients who Covered Entity determines are eligible to purchase and / or receive 340B Drugs from Covered Entity Locations , subject to the limiting definition of " Patient " set forth in 61 Federal Register 55156 ( 1996 ) , as the same may be modified or amended . All Covered Entity patients who are Medicaid beneficiaries and for whom claims for pharmaceuticals are reimbursable by a state fee - for- service Medicaid program are expressly excluded from this definition . 2090 " HRSA" means the Health Resources and Services Administration . 2 . 10 . " Inventory Replenishment Rate " means the amount due Walgreens for each 340E Drug dispensed by Walgreens but for which Walgreens does not receive replenishment from the Supplier . The Inventory Replenishment Rate will be determined in accordance with Exhibit A . 2 . 11 . " Manufacturer" means any pharmaceutical manufacturer of 340B Drugs purchased by Covered Entity and delivered to Walgreens via Supplier pursuant to the terms of this Agreement . 2 . 12 . " NDC - 11 " means a medication ' s unique 114git number containing : ( i ) the labeler code assigned by the Food and Drug Administration ; ( ii ) the product code ; and ( iii ) the package size of the pharmaceutical product . 2 . 13 . " Non - Eligible 340B Drugs " means drugs ( based upon the NDC- 11 ) that are not a 340B Drug, on the 340B Price File , and / or eligible for the 340B Drug Program . 2 . 14 . " Pharmacy Location " means the specific pharmacy location ( s ) referenced in Exhibit B , which may include retail , mail order/online , and specialty pharmacies . Walgreens shall provide Covered Entity with written notice of any change in the specific pharmacy locations through which Walgreens manages and dispenses medications pursuant to Covered Entity ' s 340B Drug Program . The notice shall be accompanied by an updated Exhibit B reflecting such change ( s ) , and shall identify the effective date of the change ( s ) , which shall not be less than thirty ( 30 ) days following the issuance of the notice . Unless Covered Entity provides Walgreens with written notice of objection to the change ( s ) prior to the effective date specified in the notice , the term " Pharmacy Location " shall be deemed to refer to the pharmacy locations listed on the updated Exhibit B as of that effective date and the parties shall cooperate in posting the revised list of Pharmacy Locations with HRSA . For purposes of clarity, the parties acknowledge and agree that the pharmacy locations listed in Exhibit B are contract pharmacies 2of24 MAT- 63397 OrangeCountyHD - WAG 340B 10312019 ( be ) V1 . 0 © 2019 Walgreen Co . All rights reserved .